Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taryn Youngstein

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Rheumatology (Oxford, England)|December 12, 2017
Adult-onset tumour necrosis factor receptor-associated periodic syndrome presenting as transfusion-dependent refractory haemophagocytosisTaryn Youngstein, Mickey B C Koh, Jose Ros Soto, et al.
JACC. Cardiovascular Imaging|July 20, 2020
The Impact of Integrated Noninvasive Imaging in the Management of Takayasu ArteritisChristopher P Uy, Jason M Tarkin, Deepa Gopalan, et al.
Nature Reviews. Rheumatology|September 4, 2024
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseasesMaya H Buch, Ziad Mallat, Marc R Dweck, et al.
Rheumatology (Oxford, England)|August 7, 2019
British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literatureDorota M Rowczenio, Taryn Youngstein, Hadija Trojer, et al.
Pharmacology & Therapeutics|February 1, 2026
Therapeutic management of inflammatory heart diseasesAldo Bonaventura, Marco Giuseppe Del Buono, Michele Golino, et al.
Expert Review of Clinical Immunology|November 4, 2020
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammationIsabelle Amigues, Alexander H Pearlman, Aarat Patel, et al.
Clinical and Experimental Rheumatology|October 8, 2013
Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritisTaryn Youngstein, James E Peters, Shahir S Hamdulay, et al.
Clinical Medicine (London, England)|May 7, 2020
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemicElizabeth Price, Elizabeth MacPhie, Lesley Kay, et al.
Scientific Reports|October 31, 2018
Novel Angiographic Scores for evaluation of Large Vessel VasculitisEnrico Tombetti, Claudia Godi, Alessandro Ambrosi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 29, 2020
Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathologyLuke Dixon, Charles Coughlan, Kushan Karunaratne, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|December 12, 2017
Adult-onset tumour necrosis factor receptor-associated periodic syndrome presenting as transfusion-dependent refractory haemophagocytosisTaryn Youngstein, Mickey B C Koh, Jose Ros Soto, et al.
JACC. Cardiovascular Imaging|July 20, 2020
The Impact of Integrated Noninvasive Imaging in the Management of Takayasu ArteritisChristopher P Uy, Jason M Tarkin, Deepa Gopalan, et al.
Nature Reviews. Rheumatology|September 4, 2024
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseasesMaya H Buch, Ziad Mallat, Marc R Dweck, et al.
Rheumatology (Oxford, England)|August 7, 2019
British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literatureDorota M Rowczenio, Taryn Youngstein, Hadija Trojer, et al.
Pharmacology & Therapeutics|February 1, 2026
Therapeutic management of inflammatory heart diseasesAldo Bonaventura, Marco Giuseppe Del Buono, Michele Golino, et al.
Expert Review of Clinical Immunology|November 4, 2020
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammationIsabelle Amigues, Alexander H Pearlman, Aarat Patel, et al.
Clinical and Experimental Rheumatology|October 8, 2013
Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritisTaryn Youngstein, James E Peters, Shahir S Hamdulay, et al.
Clinical Medicine (London, England)|May 7, 2020
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemicElizabeth Price, Elizabeth MacPhie, Lesley Kay, et al.
Scientific Reports|October 31, 2018
Novel Angiographic Scores for evaluation of Large Vessel VasculitisEnrico Tombetti, Claudia Godi, Alessandro Ambrosi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 29, 2020
Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathologyLuke Dixon, Charles Coughlan, Kushan Karunaratne, et al.
Pageof 7